Urology Doctors in Morgantown, WV Accepting Medicare

8 Urology doctors found. Showing 1 - 8

Dr. John A Battin, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 J D Anderson Dr, Suite 401, Morgantown, WV 26505 Phone: 304-599-3074    Fax: 304-599-1802

Dr. David M Hall, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 J D Anderson Dr, Suite 401, Morgantown, WV 26505 Phone: 304-599-3074    Fax: 304-599-1802

Ali John Hajiran, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: One Stadium Drive, Hsc, 9238, Morgantown, WV 26505 Phone: 203-293-1254    Fax: 304-293-4711

Dr. Hesam Farivar-mohseni, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800    Fax: 304-293-6963

Dr. Jaschar Shakuri-rad, D.O. Urology Medicare: Accepting Medicare Assignments Practice Location: 1000 J D Anderson Dr Ste 401, Morgantown, WV 26505 Phone: 304-599-3074    Fax: 304-599-1802

Dr. John Taylor Barnard Ii, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-293-3204

Tyler S Trump, Urology Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr Rm 4601, Morgantown, WV 26506 Phone: 304-598-0430

Dr. Stanley J Kandzari, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800    Fax: 304-293-6963

News Archive

FDA grants Abbott 510(k) clearance to market molecular diagnostic test for detection of chlamydia, gonorrhea

Abbott announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration to market a new, sensitive molecular diagnostic test and instrument to simultaneously detect two of the nation's most prevalent sexually transmitted diseases (STDs), gonorrhea and chlamydia, including a new variant strain of chlamydia recently discovered in Sweden.

Mitosis study identifies new potential target for cancer therapy

Structural biologists show in a new study that an apparently key step in the process of cell division depends on a unique interaction among specific proteins, including one that is strongly linked to cancer. Their hope now is that the detailed new characterization of the interaction will make it a target for exploring a new cancer therapy.

Study provides new information on why A-T disease attacks the brain

Rutgers scientists think they have found a way to prevent and possibly reverse the most debilitating symptoms of a rare, progressive childhood degenerative disease that leaves children with slurred speech, unable to walk, and in a wheelchair before they reach adolescence.

Quintiles announces strategic alliance with Movetis NV for commercialization of Resolor

Quintiles today announced a strategic alliance with Movetis NV for commercialization of its new product, Resolor (prucalopride), in the U.K. and Germany. Under the alliance, Quintiles will execute a comprehensive commercial sales effort for the product launch and provide additional services in consulting, market access, market intelligence and analytics, regulatory and post-marketing pharmacovigilance.

Read more Medical News

› Verified 1 days ago